Original reporting on changes that actually matter. No outrage, no tribal alignment. Just the mechanisms reshaping how people live, work, and invest.
Always free. No credit card.
900+
Stories
2,726
People
2,435
Organizations
Daily
Updates
Most news is filtered through political alignment, ideological framing, or audience-capture incentives. The result is coverage that emphasizes narrative reinforcement over explaining what is truly changing. Newzino pushes the opposite direction: stories selected and structured around mechanism-of-change — the real levers that reshape incentives and outcomes.
Rule Changes
Laws, regulations, court decisions
Money Moves
Big shifts in capital, ownership, funding
New Capabilities
Tech and science that expand what's possible
Force in Play
Coercive or kinetic power being used
Built World
Infrastructure, energy, physical systems
The United States has imposed economic pressure on Cuba for 64 years. Now, for the first time, Washington is threatening to punish any country that sells oil to the island. President Trump's January 29 executive order creates a tariff mechanism targeting third countries that supply Cuban fuel—a significant escalation that goes beyond traditional bilateral sanctions to coerce allies and trading partners into joining an energy blockade. The strategy has proven devastatingly effective: Cuba's national power grid collapsed entirely on March 17, 2026, leaving approximately 10 million people without electricity and triggering ten consecutive days of street protests—the most visible civil unrest in years. The blackout deepened shortages of food, medicine, and water, and included the vandalization of a Cuban Communist Party provincial office in Morón, signaling fractures in state control.
Money MovesAbra, a cryptocurrency wealth management platform that paid more than $83 million in regulatory settlements over the past two years, announced a $750 million merger with a blank-check company to list on Nasdaq. The deal with New Providence Acquisition Corp. III would deliver up to $300 million in cash to fund expansion of Abra's institutional lending, yield, and custody business—now the company's sole focus after it shut down its retail operations amid enforcement actions.
New CapabilitiesNo genuinely new class of antibiotic has reached patients since 1987. In the nearly four decades since, bacteria have steadily evolved resistance to existing drugs, and carbapenem-resistant Acinetobacter baumannii—a hospital-acquired pathogen that kills up to 60 percent of ventilated pneumonia patients—now sits atop the World Health Organization's list of critical-priority threats. On March 16, 2026, Swiss biotech BioVersys received clearance from the United States Food and Drug Administration (FDA) to begin enrolling American patients in a Phase 3 pivotal trial of BV100, a drug that cut 28-day mortality in half during earlier testing.
Track stories as they develop and see what historical figures would say about today's news. Free forever.
Start for Free ->Join the early signal trackers